The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

CSTL FINANCIAL STATEMENTS

Castle Biosciences Inc — balance sheet, income statement and cash flow trends

CSTLCastle Biosciences Inc

🇺🇸 USA · NASDAQ · Healthcare · Diagnostics & Research

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0200 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue357.3 M $Gross Profit276 M $ · 77%Operating Income-32.1 M $ · -9%Pre-tax Income-19.2 M $ · -5%Net Income to Owners-19.4 M $ · -5%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue357.3 M $+3.2%
Gross Profit276 M $-1.6%
Operating Income-32.1 M $—
EBITDA-3.2 M $-109.9%
Net Income to Owners-19.4 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M600 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets561.2 M
  • Equity470 M $84%
  • Current Liabilities56.5 M $10%
  • Long-term Liabilities34.6 M $6%

Key Figures

YoY change
Total Assets561.2 M $+3.0%
Total Liabilities91.1 M $+2.0%
Total Equity470 M $+3.2%
Cash & ST Investments266.8 M $-3.3%
Total Debt36.7 M $-1.9%
Net Debt-25.5 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-50 M050 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-20 M020 M40 M42.6 M $Operating-51.3 M $Investing-11.4 M $Financing-20.1 M $Net Change

Key Figures

YoY change
Operating Cash Flow42.6 M $-31.8%
Capital Expenditures43.1 M $+54.3%
Free Cash Flow-489 K $-101.4%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on CSTL

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.